Development, optimization and in vitro-in vivo evaluation of solid lipid microparticles for improved pharmacokinetic profile of bisoprolol
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Drug Solubulity and Delivery Systems · Analytical Methods in Pharmaceuticals · Natural Products and Biological Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (52)
Show source-provided references
1. Design and characterization of sustained release ketoprofen entrapped carnauba wax microparticles10.3109/03639045.2011.587433 ↗
2. Blood pressure control in hypertension. Pros and cons of available treatment strategies10.1097/HJH.0000000000001181 ↗
3. Benefits of once- daily therapies in the treatment of hypertension10.2147/VHRM.S17207 ↗
4. Adverse drug reaction monitoring and reporting among physicians and pharmacists in pakistan: a cross sectional study10.2174/1574886315666200427120322 ↗
5. Assessment of knowledge, attitude and practice of adverse drug reaction reporting among healthcare professionals in secondary and tertiary hospitals in the capital of Pakistan10.1016/j.jsps.2018.02.014 ↗
6. Future of 5-fluorouracil in cancer therapeutics, current pharmacokinetics issues and a way forward10.4103/JCRP.JCRP_10_19 ↗
7. Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies10.1016/j.addr.2007.10.010 ↗
8. Formulation and physicochemical characterization of buccoadhesive microspheres containing diclofenac sodium
9. Design and statistical optimization of glipizide loaded lipospheres using response surface methodology
10. Development of pioglitazone hydrochloride lipospheres by melt dispersion technique: optimization and evaluation10.7324/JAPS.2016.600118 ↗
11. Development and evaluation of sustained release Compritol® 888 ATO matrix mini-tablets10.3109/03639045.2011.638302 ↗
12. Solid lipid microparticles: formulation, preparation, characterization, drug release and applications10.1517/17425247.2.1.75 ↗
13. Primary prevention of hypertension: clinical and public health advisory from the National High Blood Pressure Education Program10.1001/jama.288.15.1882 ↗
14. Beta-adrenergic blocking drugs in the treatment of hypertension10.1080/080370501753400665 ↗
15. Preparation, in vitro evaluation and statistical optimization of carvedilol loaded solid lipid nanoparticles for lymphatic absorption via oral administration10.3109/10837450.2013.795169 ↗
16. semi-solid dispersion of carvedilol solid lipid nanoparticles for topical delivery
17. Development, optimization, and evaluation of carvedilol-loaded solid lipid nanoparticles for intranasal drug delivery10.1208/s12249-015-0440-8 ↗
18. Sustained release and permeation of timolol from surface-modified solid lipid nanoparticles through bioengineered human cornea10.1080/02713680903017500 ↗
19. Influence of formulation factors and compression force on release profile of sustained release Metoprolol tablets using Compritol®888ATO as lipid excipient.10.4103/0250-474X.169030 ↗
20. Evaluation of carvedilol compatibility with lipid excipients for the development of lipid-based drug delivery systems10.1007/s10973-015-5022-1 ↗
21. Compritol® 8 88 ATO, a l ipid excipient f or s ustained r elease of highly water soluble active formulation, scale-up and IVIVC study10.2174/1567201811310050006 ↗
22. Use of response surface methodology in the formulation and optimization of bisoprolol fumarate matrix tablets for sustained drug release
23. Encapsulation and characterization of controlled release flurbiprofen loaded microspheres using beeswax as an encapsulating agent10.1007/s10856-010-4034-4 ↗
24. Experimental research for the determination of bi-soprolol fumarate in bulk and dosage forms using liquid chromatography
25. From formulation variables to drug entrapment efficiency of microspheres: a technical review
26. Sustained release indomethacin-loaded solid lipid microparticles based on solidified reverse micellar solution (SRMS): in vitro and in vivo evaluation10.1016/S1773-2247(12)50085-7 ↗
27. In vitro and in vivo characterisation of piroxicam-loaded dika wax lipospheres
28. Mechanisms of drug release from advanced drug formulations such as polymeric-based drug-delivery systems and lipid nanoparticles10.1007/s40005-017-0320-1 ↗
29. Lipid-based drug delivery systems
30. Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery10.1208/s12249-010-9563-0 ↗
31. Benzophenone-3 entrapped in solid lipid microspheres: Formulation and in vitro skin evaluation10.1016/j.ijpharm.2010.07.028 ↗
32. Novel formulation of solid lipid microparticles of curcumin for anti‐angiogenic and anti‐inflammatory activity for optimization of therapy of inflammatory bowel disease10.1211/jpp.61.03.0005 ↗
33. Formulating SLMs as oral pulsatile system for potential delivery of melatonin to pediatric population10.1016/j.ijpharm.2014.04.055 ↗
34. Effect of processing variables on characterization of ofloxacin loaded lipospheres prepared by melt dispersion technique10.2174/1567201811310050003 ↗
35. Optimization of carvedilol solid lipid nanoparticles: an approach to control the release and enhance the oral bioavailability on rabbits10.1371/journal.pone.0203405 ↗
36. Development of novel amisulpride-loaded solid self-nanoemulsifying tablets: preparation and pharmacokinetic evaluation in rabbits10.1080/03639045.2017.1322608 ↗
37. Development of optimized self-nanoemulsifying lyophilized tablets (SNELTs) to improve finasteride clinical pharmacokinetic behavior10.1080/03639045.2017.1405977 ↗
38. Development and characterization of sustained-released donepezil hydrochloride solid dispersions using hot melt extrusion technology10.3390/pharmaceutics13020213 ↗
39. Design and development of lipospheres for controlled delivery for antimalarial drugs
40. Formulation and optimization of solid lipid nanoparticles of buspirone HCl for enhancement of its oral bioavailability10.3109/08982100903443065 ↗
41. Formulation and evaluation of sustained release matrix tablets of flurbiprofen using guar gum
42. Sustained release from hot-melt extruded matrices based on ethylene vinyl acetate and polyethylene oxide10.1016/j.ejpb.2012.08.008 ↗
43. Formulation, characterization and optimization of nebivolol-loaded sustained release lipospheres10.4314/tjpr.v18i2.2 ↗
44. Enantioanalysis of bisoprolol in human plasma with a macrocyclic antibiotic HPLC chiral column using fluorescence detection and solid phase extraction10.1248/cpb.55.227 ↗
45. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC)10.1016/j.addr.2012.09.028 ↗
46. Preparation and evaluation of 1-deoxynojirimycin sustained-release pellets vs conventional immediate-release tablets10.1080/02652048.2017.1321694 ↗
47. Formulation of ofloxacin loaded lipospheres with improved oral bioavailability10.2174/221173850104131209164546 ↗
48. Drug-excipient compatibility screening--role of thermoanalytical and spectroscopic techniques10.1016/j.jpba.2013.06.016 ↗
49. Development of dapagliflozin solid lipid nanoparticles as a novel carrier for oral delivery: statistical design, optimization, in-vitro and in-vivo characterization, and evaluation
50. Formulation and evaluation of vinpocetine loaded lipospheres
51. Fabrication of anti-vitiligo ointment containing Psoralea corylifolia: in vitro and in vivo characterization10.2147/DDDT.S114328 ↗
52. Formulation and characterization of solid lipid nanoparticles10.18579/jpcrkc/2013/12/4/79320 ↗